Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), has appointed Dr. Graham Merry, as the Company’s first Product Data Science Fellow. Leveraging the Company’s proprietary 10 million point medical cannabis patient dataset, Dr. Merry will lead Aleafia Health’s ongoing medical cannabis research. These efforts will be aimed at developing evidence-based, proprietary treatment methods and products for chronic illnesses including pain, insomnia, anxiety and eating disorders.
Read more
Aleafia Health to Accelerate Research Division with Appointment of Product Data Science Fellow
